{"altmetric_id":12390947,"selected_quotes":["Read our latest research paper on the use of VERO\u00ae radiotherapy for low burden cancer"],"citation":{"altmetric_jid":"ecancerorg","first_seen_on":"2016-10-03T08:30:00+00:00","issns":[],"journal":"ecancer","last_mentioned_on":1475517556,"links":["http:\/\/ecancer.org\/journal\/10\/677-vero-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions.php"],"title":"VERO\u00ae radiotherapy for low burden cancer: 789 patients with 957 lesions","type":"news","uri":"http:\/\/ecancer.org\/journal\/10\/677-vero-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions.php"},"altmetric_score":{"score":1,"score_history":{"1y":1,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":7474500,"mean":6.4836868429538,"rank":3849165,"this_scored_higher_than_pct":27,"this_scored_higher_than":2092828,"rank_type":"exact","sample_size":7474500,"percentile":27},"similar_age_3m":{"total_number_of_other_articles":239893,"mean":12.525163140079,"rank":131497,"this_scored_higher_than_pct":35,"this_scored_higher_than":84121,"rank_type":"exact","sample_size":239893,"percentile":35},"this_journal":{"total_number_of_other_articles":10912,"mean":2.8748987260563,"rank":6132,"this_scored_higher_than_pct":37,"this_scored_higher_than":4119,"rank_type":"exact","sample_size":10912,"percentile":37},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":2,"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Members of the public":2}}},"geo":{"twitter":{"GB":1}}},"counts":{"total":{"posts_count":3},"twitter":{"unique_users_count":3,"unique_users":["ecancer","RadiOncBOTjp","ecancer_espanol"],"posts_count":3}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ecancer\/statuses\/782860185274617856","license":"gnip","citation_ids":[12390947],"posted_on":"2016-10-03T08:29:47+00:00","author":{"name":"ecancer","url":"http:\/\/www.ecancer.org","image":"https:\/\/pbs.twimg.com\/profile_images\/449503716438056960\/SqsDdkL0_normal.png","description":"ecancer is a not for profit, open access, independent medical education platform, committed to improving cancer communication & education.","id_on_source":"ecancer","tweeter_id":"19975787","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":12882},"tweet_id":"782860185274617856"},{"url":"http:\/\/twitter.com\/RadiOncBOTjp\/statuses\/782862178911031296","license":"gnip","rt":["ecancer"],"citation_ids":[12390947],"posted_on":"2016-10-03T08:37:42+00:00","author":{"name":"RadiOncBOTjp","image":"https:\/\/pbs.twimg.com\/profile_images\/3725649276\/41ad78a831d14e941bd8f17c33acaaa7_normal.jpeg","description":"\u653e\u5c04\u7dda\u6cbb\u7642\u95a2\u9023\u306e\u30cb\u30e5\u30fc\u30b9\u30fb\u8a71\u984c\u3092\u3064\u3076\u3084\u3044\u305f\u308aretweet\u3057\u305f\u308a\u3059\u308bbot\u3002 \/ The bot tweeting or retweeting information about radiation therapy.","id_on_source":"RadiOncBOTjp","tweeter_id":"1461058674","geo":{"lt":null,"ln":null},"followers":362},"tweet_id":"782862178911031296"},{"url":"http:\/\/twitter.com\/ecancer_espanol\/statuses\/783003499202224132","license":"gnip","citation_ids":[12390947],"posted_on":"2016-10-03T17:59:16+00:00","author":{"name":"ecancer en espa\u00f1ol","url":"http:\/\/www.ecancer.org\/spanish","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000103922296\/c5a7dd69f291e06c34e863daf5f4c779_normal.png","description":"Somos el canal l\u00edder en Oncolog\u00eda comprometido a mejorar la comunicaci\u00f3n del C\u00e1ncer. \u00a1Visita nuestra prestigiosa revista m\u00e9dica!","id_on_source":"ecancer_espanol","tweeter_id":"1530437286","geo":{"lt":null,"ln":null},"followers":1506},"tweet_id":"783003499202224132"}]}}